Par Pharmaceutical Companies, Inc. - Strategy and SWOT Report
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Par Pharmaceutical Companies, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Par Pharmaceutical Companies, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Par Pharmaceutical Companies, Inc. including a breakdown and examination of key business segments
Intelligence on Par Pharmaceutical Companies, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Par Pharmaceutical Companies, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Par Pharmaceutical Companies (Par or 'the company') is a privately-held specialty pharmaceutical company. It is engaged in the production, marketing, and distribution of generic drugs and innovative proprietary pharmaceuticals for specialty markets. The company operates in the US. The company is headquartered in Woodcliff Lake, New Jersey, and employed 600 people. TPG, a US-based global private investment firm, completed the acquisition of Par Pharmaceutical Companies for $1.9 billion in September 2012. Par is a privately-held company, and does not disclose its financial information to the public. Hence, the company's financial information is not available.
Reasons to Purchase:
Gain understanding of Par Pharmaceutical Companies, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Par Pharmaceutical Companies, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Par Pharmaceutical Companies, Inc.’s business structure, strategy and prospects